Montreal, Canada

Simon Woo

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Astrazeneca Ab. Active years: 2008-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Simon Woo. Retrieved from https://idiyas.com/inventor/simon-woo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Quebec, CA (2008)
  • Montreal, CA (2011)

Company Filing History:


Years Active: 2008-2011

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Simon Woo: Innovator in Pharmaceutical Compounds

Introduction

Simon Woo is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of new compounds that have therapeutic applications.

Latest Patents

Simon Woo holds 2 patents, with his latest inventions focusing on compounds that are beneficial in pain management. One of his notable patents involves Benzodiazepine derivatives, which are described as compounds of Formula (I). These compounds, along with their salts and enantiomers, are prepared for use in pharmaceutical compositions, showcasing their potential in therapeutic applications.

Career Highlights

Simon Woo is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to explore innovative solutions in the pharmaceutical industry, contributing to advancements in pain management therapies.

Collaborations

Throughout his career, Simon has collaborated with esteemed colleagues, including Miroslaw Jerzy Tomaszewski and Carmen Leung. These collaborations have fostered a productive environment for innovation and research.

Conclusion

In summary, Simon Woo is a distinguished inventor whose work in pharmaceutical compounds has the potential to impact pain management therapies significantly. His contributions to the field are noteworthy and reflect his commitment to innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…